ENGN

enGene TherapeuticsB

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

RSI (14)

29.0

Oversold

MACD Hist

0.17

Bullish

ATR (14)

0.13

Normal

Vol Z (20)

-0.52

Normal

RET 20D

-77.9%

Negative

Dist 52W High

-85.7%

Below High

Technical chart

1 Year

Candles, moving averages, and volume using the current RankAlpha theme.

As of 2026-06-02

Price

SMA 20

SMA 50

SMA 200

Trend readout

Technical readout

Trend

Downtrend (SMA20 < SMA50 < SMA200)

Momentum

Negative momentum · 20D -77.9% · 60D -75.3%

RSI / MACD

RSI 29.0 (Oversold) · MACD hist +0.17

Volatility

Volatility normal (Z -0.52)

SMA20

2.33

SMA50

5.36

SMA200

7.25

EMA12

2.02

EMA26

3.20

BB Upper

6.38

BB Mid

2.33

BB Lower

-1.71

RET 5D

+1.2%

RET 20D

-77.9%

RET 60D

-75.3%

RET 120D

-78.9%

As of 2026-06-02 • Updated nightlySource: Internal modelMethodology